Premium
Palvella Therapeutics Inc (PVLA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | Institution | 1 153 496 | 8,04% | US$ 157,11M | 2026-03-31 |
| First Light Asset Management, LLC | Institution | 980 758 | 6,84% | US$ 133,58M | 2026-03-31 |
| BVF Partners L.P. | Institution | 960 989 | 6,70% | US$ 130,89M | 2026-03-31 |
| Frazier Life Sciences Management, LP | Institution | 882 400 | 6,15% | US$ 120,18M | 2026-03-31 |
| Mr. Wesley Kaupinen | Initiés | 825 819 | 5,76% | US$ 112,48M | 2026-04-13 |
| Averill Master Fund, Ltd. | Institution | 714 463 | 4,98% | US$ 97,31M | 2025-09-30 |
| BlackRock, Inc. | Institution | 686 853 | 4,79% | US$ 93,55M | 2026-03-31 |
| Samsara Biocapital, L.P. | Institution | 679 486 | 4,74% | US$ 92,55M | 2024-12-20 |
| Jennison Associates LLC | Institution | 640 611 | 4,47% | US$ 87,25M | 2026-03-31 |
| Integrated Financial Group | Institution | 559 949 | 3,90% | US$ 76,27M | 2025-04-14 |
| Vanguard Capital Management, LLC | Institution | 477 294 | 3,33% | US$ 65,01M | 2026-03-31 |
| Petrichor Healthcare Capital Management LP | Institution | 477 213 | 3,33% | US$ 65,00M | 2026-04-13 |
| Biotechnology Value Fund L.P. | Institution | 471 202 | 3,29% | US$ 64,18M | 2025-12-31 |
| State Street Global Advisors, Inc. | Institution | 458 999 | 3,20% | US$ 62,52M | 2026-03-31 |
| Frazier Life Sciences Public Fund, L.P. | Institution | 440 575 | 3,07% | US$ 60,01M | 2024-12-13 |
| Federated Hermes, Inc. | Institution | 433 015 | 3,02% | US$ 58,98M | 2026-03-31 |
| Cdk Associates, LLC | Institution | 418 667 | 2,92% | US$ 57,02M | 2024-12-20 |
| T. Rowe Price Group, Inc. | Institution | 402 564 | 2,81% | US$ 54,83M | 2026-03-31 |
| Frontier Capital Management Co LLC | Institution | 374 035 | 2,61% | US$ 50,94M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 341 883 | 2,38% | US$ 46,56M | 2025-12-31 |
| Woodline Partners LP | Institution | 317 517 | 2,21% | US$ 43,25M | 2026-03-31 |
| Emerald Advisers, LLC | Institution | 267 320 | 1,86% | US$ 36,41M | 2026-03-31 |
| AllianceBernstein L.P. | Institution | 262 835 | 1,83% | US$ 35,80M | 2026-03-31 |
| Artal Group S.A. | Institution | 257 485 | 1,80% | US$ 35,07M | 2026-03-31 |
| Eventide Asset Management, LLC | Institution | 233 248 | 1,63% | US$ 31,77M | 2026-03-31 |
| FMR LLC | Institution | 215 774 | 1,50% | US$ 29,39M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 206 404 | 1,44% | US$ 28,11M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 205 609 | 1,43% | US$ 28,00M | 2026-03-31 |
| PRIMECAP Management Company | Institution | 195 030 | 1,36% | US$ 26,56M | 2026-03-31 |
| Artisan Partners Limited Partnership | Institution | 193 796 | 1,35% | US$ 26,40M | 2026-03-31 |
| Mr. George Jenkins | Initiés | 187 616 | 1,31% | US$ 25,55M | 2026-04-13 |
| The Goldman Sachs Group, Inc. | Institution | 186 031 | 1,30% | US$ 25,34M | 2026-03-31 |
| Alyeska Investment Group, L.P. | Institution | 179 922 | 1,25% | US$ 24,51M | 2026-03-31 |
| UBS Asset Management AG | Institution | 174 438 | 1,22% | US$ 23,76M | 2026-03-31 |
| First Turn Management, LLC | Institution | 148 093 | 1,03% | US$ 20,17M | 2026-03-31 |
| Dellora Investments LP | Institution | 141 079 | 0,98% | US$ 19,21M | 2024-12-13 |
| OrbiMed Advisors LLC | Institution | 134 600 | 0,94% | US$ 18,33M | 2026-03-31 |
| Frazier Life Sciences Public Overage Fund, L.P. | Institution | 129 905 | 0,91% | US$ 17,69M | 2024-12-13 |
| Dellora Investments Master Fund LP | Institution | 123 034 | 0,86% | US$ 16,76M | 2024-12-13 |
| Norges Bank Investment Management | Institution | 120 343 | 0,84% | US$ 16,39M | 2025-12-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
